1. Home
  2. VCIG vs REVB Comparison

VCIG vs REVB Comparison

Compare VCIG & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • REVB
  • Stock Information
  • Founded
  • VCIG 2013
  • REVB 2020
  • Country
  • VCIG Malaysia
  • REVB United States
  • Employees
  • VCIG N/A
  • REVB N/A
  • Industry
  • VCIG Diversified Commercial Services
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • REVB Health Care
  • Exchange
  • VCIG Nasdaq
  • REVB Nasdaq
  • Market Cap
  • VCIG 5.8M
  • REVB 5.4M
  • IPO Year
  • VCIG 2023
  • REVB N/A
  • Fundamental
  • Price
  • VCIG $1.30
  • REVB $0.40
  • Analyst Decision
  • VCIG
  • REVB
  • Analyst Count
  • VCIG 0
  • REVB 0
  • Target Price
  • VCIG N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • VCIG 2.0M
  • REVB 6.8M
  • Earning Date
  • VCIG 01-28-2025
  • REVB 11-08-2024
  • Dividend Yield
  • VCIG 37.69%
  • REVB N/A
  • EPS Growth
  • VCIG N/A
  • REVB N/A
  • EPS
  • VCIG 7.82
  • REVB N/A
  • Revenue
  • VCIG $23,548,256.00
  • REVB N/A
  • Revenue This Year
  • VCIG N/A
  • REVB N/A
  • Revenue Next Year
  • VCIG N/A
  • REVB N/A
  • P/E Ratio
  • VCIG $0.17
  • REVB N/A
  • Revenue Growth
  • VCIG 89.38
  • REVB N/A
  • 52 Week Low
  • VCIG $1.25
  • REVB $0.28
  • 52 Week High
  • VCIG $103.39
  • REVB $25.26
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 37.14
  • REVB 39.87
  • Support Level
  • VCIG $1.68
  • REVB $0.39
  • Resistance Level
  • VCIG $2.15
  • REVB $0.53
  • Average True Range (ATR)
  • VCIG 0.25
  • REVB 0.13
  • MACD
  • VCIG -0.00
  • REVB 0.00
  • Stochastic Oscillator
  • VCIG 5.56
  • REVB 7.54

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: